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Hemagglutination and hemolytic titrations of antisera using red cells to which 
antigens have been conjugated with bis(diazo)benzidine have been used as a 
measure of antibody activities (1--4) in this laboratory. Hemagglutination and 
immune hemolysis fitrations have comparable sensitivities. Immune hemolysis, 
however, can be modified to give a high degree of precision (5).  Both methods 
have been used to advantage with a number of protein antigens; i.e.,  insulin, 
egg  albumin,  bovine  serum  albumin,  human  gamma globulin,  ferrifin,  and 
others (2). 
This investigation is concerned with the diminished immune hemolysis and 
relatively elevated hemagglutination titers noted with three different immuno- 
logical systems involving sialic acid-containing antigens. These glycoprotein 
immune systems were capable of complement fixation. Consequently, the di- 
rnlnished immune hemolysis could not be attributed to the lack of complement 
fixation. Large amounts of these three glycoproteins in solution did not inter- 
fere with immune hemolysis observed with insulin and homologous antibody. 
When red cell preparations were sensitized with a mixture of sialic acid-contain- 
ing glycoprotein and  insulin, immune hemolysis by insulin antisera was  di- 
minished. Red cells treated with neuraminidase to remove sialic acid, and then 
incubated with complement, hemolyzed in the absence of any known immune 
reaction. Furthermore, such hemolysis of neuraminidase-treated ceils by com- 
plement could be interfered with by conjugating sialic acid-containing glyco- 
proteins to the cell surface. 
These  observations are  consistent with the postulate that during immune 
hemolysis a sialic acid-containing substrate is enzymatically cleaved from the 
cell surface prior to lysis of the red cell. 
* Presented in part before  the 48th Annual  Meeting  of the Federation  of American  Societies 
for Experimental  Biology,  April, 1964 (abstract in Fed. Proc., 1964, 28, 2430). 
These studies were supported by United States Public Health Service Grant AM-06001, 
and, in part, by grants from the California  Institute for Cancer Research and Eli Lilly and 
Co. 
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Materials and Methods 
Antigens 
Insulin.--CrystalFme beef insulin (Lot No.  719106) 1 was a preparation with a potency of 
27.0 units per nag. Some hyperglycemic factor was present in this preparation. 
Alum-precipitated insulin was prepared by suspending 50 mg insulin in  10 ml buffered 
saline and then adding 0.5 ml of 1 per cent  alum,  A1NI-I4(SO4)2.12HeO.  Alum-precipitated 
insulin was used for booster injections during the course of immunization. The preparation 
used for initial immunization contained 1.5 ml (7.5  mg) of alum-precipitated insulin plus 10 
ml of complete Freund's adjuvant obtained from Hyland Laboratories, Los Angeles, California. 
Human Chorioni¢ Gonadotropin (HCG) (Lot Nos. 90259 and  9027g).--This  was  obtained 
from Vitamerican Corporation, Little Falls, New Jersey. These preparations contained about 
2,500 IU per mg with a carbohydrate content ranging from 20 to 30 per cent. A  minimum of 
8 immunological moieties could be identified by immunoelectrophoresis of the HCG prepa- 
ration with homologous antiserum (6). For immunization 5 mg of HCG was suspended in 1 ml 
of complete Freund's adjuvant• HCG (5 mg/ml) in buffered saline was used for booster injec- 
tions. 
Human  Transferrin  (HT).--Human  apotransferrin  was  obtained  from  Behringwerke, 
Marburg, Germany (Lot No. 1227/34). When assayed by titration with Fe-59, i mg was found 
to contain 0.133 #mole.  2 
For immunization, HT was suspended by sonieation in Freund's adjuvant at a concentra- 
tion of 4 mg/ml. HT (4 mg/ml) in buffered saline was used for booster injections. 
Rabbit Transferrin  (RT).--Rabbit transferrin was obtained from Pentex, Inc., Kankakee, 
Illinois (Lot No.  1).  When assayed speetrophotometrieally at 465 m#,  1 mg was found to 
•  .  1.  om  contain 0.13 #mole, assuming E1 m,o~nt --- 0.68 (7) and tool wt  --  67,000 (8). This preparation 
was contaminated with a  small amount of heme-protein (less than 5 per cent) but was used 
without further purification. 
The RT used for immunization was prepared in the same manner as the HT. 
A ntiser  a 
Rabbit Antisera  to the Various Antigens  Used.--These were developed in adult male and 
female New Zealand white rabbits by injecting 0.2 ml of antigen in Freund's adjuvant into 
each toe pad. 3 to 4 weeks later, 2.5 to 5.0 mg of antigen in 0.5 to 1.0 ml were injected intra- 
venously and followed by a second booster within 48 to 72 hours. A 3 to 5 ml test sample of 
blood was taken within  7  to 19 days following the second booster. When adequate  titers 
of antibody were observed, 50 to 60 ml of  blood were  taken  from  the  marginal ear vein. 
When antibody levels were low,  the booster injections were repeated. Rabbits receiving in- 
sulin also received 25 ml of 50 per  cent  glucose  subcutaneously  to  minimize hypogiycemic 
reaction. 
Blood samples were allowed to stand at room temperature (25°C)  for 2 hours and then 
stored  overnight at 4°C.  The following morning sera were  separated  by centriiugation at 
approximately 2500 g for 20 minutes. Antibody titers of the sera were determined by hemag- 
glutination, the sera divided into aliquots, and stored at --80°C until used. 
Rabbit antisera were inactivated at 56°C for 30 minutes and adsorbed with 10 mg of sheep 
red cell stroma/ml serum (9) at room temperature for 10 minutes. 
i We wish to thank Dr. Otto K. Behrens, Eli Lilly and Co., Indianapolis, Indiana, for the 
generous supply of cyrstaliine beef insulin. 
Dr.  Paul  Saltman,  Department  of  Biochemistry,  University  of  Southern  California, 
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Guinea Pig Antisera.--Guinea pig antisera to the various antigens were developed in adult 
male and female mongrel guinea pigs by injecting 0.2 ml of antigen in Freund's adjuvant into 
each paw pad. They were desensitized 3 to 4 weeks later by the successive subcutaneous in- 
jection of 1,  10, and 100 pg of antigen at 45 minute intervals and a  second 100 pg antigen 
injection 1 hour later. The animals were constantly observed and 0.5 ml of 1:100,000 epineph- 
rine was injected intraperitoneally when symptoms of anaphylaxis appeared.  The animals 
immunized with insulin received 4 ml of 50 per cent glucose following each series of inocula- 
tions. 
One week following the desensitization procedure, an animal was selected at random and a 
7 to 10 ml test sample of blood was taken by cardiac puncture. If an adequate antibody titer 
was observed, all the guinea pigs which had been immunized were anesthetized with intraperi- 
toneal nembutal (0.5 ml of 60 mg/ml), and exsanguinated from the carotid artery within 1 to 
2 days after the test sample was obtained. Guinea pig antisera were treated in the same man- 
ner as the rabbit antisera, except that the adsorption with stroma was not performed. 
Solulions 
Buffered saline consists of 0.15 ~  NaC1 in 0.01 xf phosphate buffer, pH 7.4. 
Cacodylale buffer contains 0.137 K sodium cacodylate and 0.007 ,s CaC12; pH was adjusted 
to 6.4 with 4 ~ HC1 (10). 
Veronal-Buffered Saline  (VBS).--The diluent used for titrating complement and  immune 
hemolysis titrations was veronal-buffered saline, pH 7.4 (11), containing 5  X  10  -4 x¢ MgCI2 
and 1.5 X  10-s u  CaCI2. 
VBS-Albumin.--The diluent used for hemaggiutination titrations was VBS containing 1.5 
gm bovine serum albumin (Armour Company) per liter. Prior to use, the diluent was incubated 
at 80"C for 1 hour and then cooled to 0*C in a water hath. Much of the non-specific agglutina- 
tion observed at high dilution of antiserum was eliminated with this diluent. 
Insulin.bThe  insulin solution was made up in a  concentration of 1 mg/ml. Insulin was 
dissolved in 0.01  ~  NaOH,  equal to one-half the desired  final volume, and diluted to final 
volume with 0.22 M phosphate buffer, pH 7.4. This stock insulin solution was  stored at 4"C 
and discarded ff not used within 3 days. 
Neuraminidase (Vibrio cholerae).--Neuraminidase  was obtained from General Biochemicals, 
Chagrin Falls, Ohio (Lot No. 52632) and had a specific activity of 100 units/ml (10 units/#g 
N). Prior to use the neuraminidase (1.5 ml) was dialyzed against a minimum of three changes 
of 10 volumes each of cacodylate buffer at 0°C for 12 hours. 
Complement.--Adsorbed  complement (C'~) was used for the hemolytic titration of insulin 
antibodies. Pools of fresh guinea pig sera were adsorbed with 10 mg/ml of the $2 fraction of 
sheep erythrocyte stroma (9) at room temperature (25°C)  for 10 minutes while gently agitated 
and then centrifuged at approximately 2000 g at 4°C for 15 minutes. 
Titration of Complement (ll-14).--Titers of C.  ~ were determined by 50 per cent hemolytic 
end points. A unit of complement is defined as the smallest amount of Ca which will cause lysls 
of 50 per cent of the sensitized cells (1 ml of a  1.25 per cent suspension) in a final volume of 
1.5 ml after 30 minutes at 37°C. 
Erythrocyte Preparation.--Sheep  red cells were stored as sheep blood collected in an equal 
volume of Alsever's solution. This suspension was stored at 4°C and used for a  period of 14 
days. 
Bi.s(diaso)bensidine (BDB) was prepared according to Kabat and Mayer (15). The reaction 
was carried out in the presence of ice crystals. The final product was a  pale yellow solution. 
This material was empirically standardized by adding 7 ml of 0.11 a  phosphate buffer to 0.5 
ml BDB  (1:15 BDB). A deep reddish brown color developed immediately and the solution 
became turbid within 90 seconds (4- 5 seconds). In the event the solution did not immediately 844  INTERFERENCE  WITH  IMMUNE  HEMOLYSIS 
turn deep reddish brown, the onset of turbidity was also prolonged. A few crystals of benzidine 
were then added and the solution retested. When the turbidity developed rapidly (less than 
80 seconds),  small amounts of sodium nitrite were added to the solution. When the desired 
preparation was obtained,  the stock BDB  was divided into 0.5  ml aliquots and  stored  at 
-80°C. Under these conditions BDB was active for at least 9 months. 
Insulin-Conjugated Red Cells (Insulin-Cdls).--Insulin-cells were prepared by conjugating 
insulin to washed sheep red cells with BDB as previously described (1). 
tiC, Conjugated Red Cells (tICG-Cdls).--Washed, packed,  sheep red cells (0.1  ml) were 
suspended in a  solution containing 1.5 mg of HCG in 3.0 ml bufered saline, and 0.6 ml of 
freshly diluted 1:15 BI)B was added (3). The suspension  was shaken gently for 10 minutes at 
room temperature and washed twice with veronal-buffered saline. The washed, packed, HCG- 
cells were resuspended in 5 ml of VBS-albumin for hemagglutination titrations and in 5 ml of 
VBS for immune hemolysis titrations. 
Transferrin-Conjugated Red Cells (RT-Cdls and tIT-Cdls).--Washed,  packed,  sheep  red 
cells (0.1 ml) were suspended in a solution containing 1.5 ml transferrin (1 mg/ml saline)  and 
0.5 ml buffered saline to which 0.35 ml of freshly diluted 1 .'15 BDB was added. The suspension 
was shaken gently for 15 minutes at room temperature, washed twice, and resuspended to 5 ml 
with VBS. The amounts of reagents and the procedures were identical for the preparation of 
both  HT-cells and  RT-cells. 
Mixed-Seneigred  Cells (liT-I-Calls  and  RT-I-Cdls).--Washed,  packed,  sheep  red  cells 
(0.2 ml) were suspended in a solution containing 0.5 ml of insulin (1 mg/ml), 2.5 ml of either 
HT or RT (1 mg/ml), and 0.7 ml of 1:15 BDB. This mixture was incubated at room tem- 
perature for 15 minutes with gentle shaking, washed twice, and resuspended to 10 ml with 
VBS. The presence of both transferrin and insulin on the red cell surface was demonstrated 
by hemagglutination (Table V). 
Neuraminidase-Treated Red Ce//s.--These were prepared by a modification of the method 
of Eylar, Madoff, Brody, and Oncley (10).  Sheep red cells were washed ten times in isotonic 
buffer, pH 7.2  (0.135 u  sodium chloride and 0.02  ~s sodium phosphate).  Cacodylate buffer 
(0.3 ml) and 0.2 ml neur~minldase (20 units) which had been dialyzed against cacodylate buffer 
were added to 0.3 ml of washed, packed, sheep red ceils. This ceil suspension was incubated 
at 37°C for 30 minutes and washed three times with approximately 100 volumes of cold (0°C) 
VBS and resuspended to a final volume of 30 ml in VBS. 
The controls for neuraminidase-treated red cells were treated in a  similar fashion  except 
that 0.2 ml of cacodylate buffer was added to the suspension  of red cells instead of neuramini- 
dase. 
Titration 
ttemagglutination  Titration.--Antisera were titrated  by the hemagglutination method  of 
Arquilla and Stavitsky (1), employing one of the various antigen-cell preparations and homol- 
ogous  antiserum.  The diluent used for titrations was VBS-aibumin. The solution consisted 
of 0.5 ml antisera, 0.05 ml for testing materials by hemagglutination inhibition, and 0.05 ml 
of antigen-cells. The hemagglutination titers were arbitrarily designated as the highest dilution 
of antiserum capable of agglutinating 0.05 ml of a 2.0 per cent suspension  of antigen-cells in a 
final volume of 0.6 ml, and expressed as the reciprocal of the titer. 
Antibody  Titration by Immune Hemolysis.--This was performed by a  modification of the 
immune hemolysis technique previously described (5). Antisera, serially diluted with VBS to 
a final volume of 0.5 ml, were cooled in an ice bath, and 20 units of C', in 0.3 ml VBS were then 
added. Antigen-cells (0.2 ml) were added to the solution, evenly suspended by gentle shaking, 
and incubated in a 37°C water bath for 30 minutes. The non-hemolyzed cells were separated 
by centrifugation at  4°C,  at  approximately  2000  g for  10  minutes.  The  supernatant  was ARQUILLA,  HAMLIN,  HAMASHIGE,  AND  MILLER  845 
decanted and 2 ml water added to each sample. The degree of hemolysis was measured by 
adsorption of each sample at 580 m/z with a Beckman model DB spectrophotometer. 
Hemolysis of antigen-cells by homologous antisera in the presence of excess C~ has been 
shown to be a precise measure of antibody concentration (5).  Specificity of the system was 
controlled by inhibition of hemolysis with homologous antigen. 
Complement Fixo/Jon.--This  was performed in a  VBS diluent in a  final volume of 1 ml, 
consisting of 0.25 ml C~ (10 to25 units), 0.5 ml diluted antiserum, and 0.25 ml antigen varying 
between 5 and 250/~g. This mixture was incubated for about 18 hours in a 0°C water bath, 
and CSa titrations were performed as previously described. The results were expressed as the 
number of units fixed (Tables HI and IV). 
TABLE I 
Comparison of Hemagglutination Titers  and Immune Hemolysis  Titers of Insulin Antisera 
Insulin antiserum 
C32d 
C33d 
C38c 
Guinea pig pool 
Hemagglutlnation* 
640 
160 
640 
160 
Antibody titer 
Immune hemolysis~ 
320 
320 
640 
120 
* Reciprocal of highest  dilution of antiserum  which will agglutinate  insulin-conjugated 
erythrocytes. 
Reciprocal of highest dilution of antiserum which will hemolyze 50 per cent of the insulin- 
conjugated  erythrocytes added. 
RESULTS 
Comparison of ttemagglutination with Immune  Hemolysis Titers of Insulin 
Antisera and Glycoprotein Antisera.--Insulin  antibody titers measured by im- 
mune hemolysis and hemagglufination of one guinea pig and three rabbit anti- 
sera were compared, using aliquots of the same insulin-cell preparation (Table 
I). The rabbit insulin antisera (C32d, C33d, and C38c) had hemagglutination 
fiters (640, 160, 640) which approximated the immune hemolysis titers (320, 
320, and 640). The hemagglutinafion titer (160) and immune hemolysis titer 
(120) of the guinea pig insulin antiserum were also similar (Table I). It appears, 
therefore, that the titer of an individual insulin antiserum measured by hemag- 
glutination agrees favorably with the titer of the same antiserum measured by 
immune hemolysis. 
In contrast, a marked disparity is noted between the immune hemolysis and 
hemagglutination titers of antisera prepared against three different glycopro- 
teins (HCG, HT, and RT).  Immune hemolysis with these three antigens is 
markedly suppressed and occasionally not measureable. On the other hand, the 
hemagglutination titers of antisera prepared against the three glycoproteins 846  INTERFERENCE  WITH  IM]VtUNE  HEMOLYSIS 
have been consistently higher than immune hemolysis titers (Table II and Fig. 
1). 
The difference between hemagglutination  and immune  hemolysis titers  of 
HCG antisera from three rabbits and one guinea pig is presented in Table II. 
TABLE II 
Comparison of Hemagglutination Titers and Immune Hemolysis  Titers of HCG Antisera 
HCG antiserum 
RBIL 
RB2J 
C12N 
Guinea pig pool 
Hemagglutination* 
40,000 
10,000 
20,000 
2,560 
Antibody titer 
Immune hemolysis~: 
350 
260 
320 
0 
* Reciprocal of highest dilution of antiserum which will agglutinate HCG-conjugated 
erythrocytes. 
:~ Reciprocal of highest dilution  of antiserum which will hemolyze 50 per cent of the 
HCG conjugated erythrocytes  added. 
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FzG. 1. Comparison of hemagglutination and immune hemolysis  titers of insulin and trans- 
ferrin antisera. 
The three rabbit antisera (RB 1L, RB 2J,  and C  12N) had elevated  hemag- 
glutination  titers  (40,000,  10,000,  and  20,000,  respectively)  whereas  the  im- 
mune hemolysis titers of aliquots of the same antisera against the same HCG- 
cell preparation were much lower (350, 260, and 320). Immune hemolysis could 
not be demonstrated with the guinea pig antiserum which had a hemagglutina- 
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Fig.  1 is an example of similar observations noted when human and rabbit 
transferrin were used as antigens. The hemagglutination titer was 1600 for both 
transferrin immune systems and 640 for the insulin immune system. The im- 
mune hemolysis titer in the insulin system was the same as the hemagglutina- 
tion  titer,  whereas,  no  demonstrable  immune  hemolysis  was  observed  with 
either transferrin system (Fig. 1). 
TABLE  III 
Spezif~ity  of Complement Fixation in  HCG Anti-HCG and  Insulin  Anti-Insulin  Systems 
Units complement* fixed 
HCG antibody +  HCG  22 
HCG Antibody +  insulin  None 
Insulin antibody +  insulin  22 
Insulin antibody +  HCG  None 
* Twenty-five 50 per cent hemolytic units CI. were used in all experiments. 
TABLE IV 
Complement Fixation in HT Anti-HT and RT Anti-RT Systems* 
Units~; complement  added  Units complement  fixed 
HT +  1Tr antibody 
HT 
HT antibody 
RT +  RT antibody 
RT 
RT antibody 
12 
12 
12 
11 
11 
11 
9.5 
None 
None 
7 
None 
None 
* HT =  human transferrin; RT -- rabbit transferrin. 
:~ 50 per cent hemolytic units. 
It was not known whether reduced hemolysis in the three glycoprotein im- 
mune systems was due to poor complement fixation or to non-specific anticom- 
plementary factors. A third possibility was interference with immune hemolysis 
by the carbohydrate moiety on the glycoprotein antigens. 
Complement Fixation by Insulin and Glycoprotein Immune Systems.--In view 
of  the  reduced  hemolysis in  glycoprotein  immune  systems as  compared  to 
hemolysis in the insulin immune system, the complement-fixing abilities of both 
were tested. In addition,  the presence of non-specific anticomplementary fac- 
tors in the anfisera and antigen preparations was investigated. 
Complement is fixed in the presence of HCG antibody and HCG (Table III). 
This was also observed with insulin antibody and insulin. The fact that no com- 
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indicates that the HCG and insulin anfisera and also the insulin and HCG are 
not anticomplementary. 
In addition, complement fixation was demonstrated with both the RT and 
HT immune systems (Table IV). It was also noted that neither RT nor HT nor 
homologous antisera were anticomplementary. 
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FIG. 2. Effect of soluble transferrin on insulin immune hemolysis. 
Consequently, the decreased ability of glycoprotein antisera to cause immune 
hemolysis of glycoprotein-cells in the presence of excess complement cannot be 
explained on the basis of the inability of the glycoprotein immune systems to 
fix complement. 
Effect  of  Soluble Glycoprotein on  Insulin  Immune  Hemolysis.--Whether 
glycoproteins in solution could also inhibit immune hemolysis was tested by 
adding soluble glycoproteins to the insulin immune hemolysis system (Fig. 2). 
The immune hemolysis of insulin-cells by homologous antisera was not inter- 
fered with when relatively large quantities (500/~g) of RT, HT, or HCG were 
added to the insulin immune system (Fig. 2). Master dilutions of insulin antisera 
were subdivided into four series. VBS was added to the first (control) series of ARQUILLA, HAMLIN, HAMASHIGE, AND MILLER  849 
antiserum dilutions, the second was preincubated with 500 ttg of HT, the third 
with 5 #g of HT, and the fourth with 50/zg of insulin. The immune hemolysis 
titration curves obtained when either 500/~g or 5 gg of HT was preincubated 
with insulin antiserum were very similar to those obtained when diluent (VBS) 
was preincubated with the same dilutions of antiserum. On the other hand, there 
was marked inhibition of hemolysis by preincubation of 50 gg of insulin with the 
antiserum. Therefore, glycoprotein in solution probably does not affect the im- 
mune hemolysis of antigen-coated cells by homologous antisera. Consequently, 
the inhibitory effect of glycoprotein on immune hemolysis may require that the 
carbohydrate-containing proteins be in intimate contact with the red cell sur- 
face. 
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Fzo. 3. Interference by transferrin with  insulin immune hemolysis of mixed-sensitized 
cells. 
Interference with Hemolysis in the Insulin Immune System by Transferrin.-- 
Experiments were designed to test whether glycoproteins must be attached to 
the red cell surface to interfere with immune hemolysis. The hemolysis of red 
cells to which both transferrin and insulin were conjugated was compared to 
the hemolysis of red cells to which insulin alone was conjugated (Fig.  3  and 
Table VI). The presence of both transferrin and insulin on the surface of the red 
cells (mixed-sensitized cells) was demonstrated by hemagglutination (Table V). 
Anti-HT serum agglutinated these mixed-sensitized cells at a  titer of 12,800. 
This agglutination was inhibited by HT but not by insulin. Insulin antiserum 
agglutinated the same cell preparation at a titer of 640 and was inhibited by in- 
sulin but not by HT. Consequently, both insulin and transferrin were attached 
to the cell surface and neither of these attached antigens noticeably interfered 
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The immune hemolysis of mixed-sensitized cells was compared to that of cells 
sensitized with insulin alone  (Fig.  3).  This  insulin antiserum had  the  same 
hemagglufination titer (640)  against both cell preparations. The hemolysis of 
mixed-sensitized cells, however, was markedly less than the hemolysis of cells 
sensitized with insulin alone. Table VI summarizes the results of two experi- 
ments using two different guinea pig insulin antisera. In the first experiment, 
TABLE  V 
Mixed Sensitization  of Erythrocytes with Transferrin and Insulin 
Antiserum 
Antibody hemagglutination  tlter* 
Inhibited with  Inhibited with 
Non-inhibited  insulin  trnnsferrin 
Anti-insulin  640  0  640 
Anti-transferrin  12,800  12,800  0 
* All titers are expressed as the reciprocal of the highest dilution of antiserum capable of 
agglutinating cells sensitized with both insulin and transferrin. 
TABLE  VI 
Interference by Transferrin  with Hemolysis of Mixed-Sensitized  Cells by Insulin Antisera 
Insulin antisera ............... ...  C 18  L 74 
Sensitized cells ....  HT-I  I  RT-I  I 
Hemolysis* per cent  35.6  100  40.5  100 
Hemagglutination titer  640  640  2,560  2,560 
HT-I-cells are sheep red cells sensitized with both human transferrin and insulin. 
RT-I-cells are sheep red cells sensitized with both rabbit transferrin and insulin. 
I-cells are sheep red ceils sensitized with insulin. 
* The estimate of per cent lysis of mixed-sensitized ceils compared to lysis of insulin ceils 
was obtained by dividing the area under the curve of the hemolytic titration of the mixed- 
sensitized cells by the area under the curve of the hemolytic titration of the insulin-cells. 
which has already been presented graphically (Fig. 3), guinea pig insulin anti- 
serum (C 18) and mixed-sensitized ceils prepared with HT and insulin (HT-I- 
cells) were used. In the second experiment guinea pig insulin antiserum (L 74) 
and mixed-sensitized cells prepared with RT and insulin (RT-I-cells) were used. 
In both of these experiments the hemagglutination titer of the antisera was the 
same when either the mixed-sensitized cells or the insulin-cells were used as in- 
dicators. The immune hemolysis of HT-I-cells by C 18 insulin antiserum was 65 
per cent less than the immune hemolysis of insulin-cells.  Similarly, the. hemolysis 
of RT-I-cells by L 74 insulin antiserum was 60 per cent less than the hemolysis 
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area under the curve of the hemolytic titration obtained with mixed-sensitized 
cells by the area under the curve of the hemolytic titration  obtained with in- 
sulin-cells. 
RT, HT, and possibly HCG interfere with the hemolytic phase of immune 
hemolysis.  These three glycoproteins in solution had no such effect (Fig.  2), 
whereas glycoproteins attached to the red cell surface interfered with immune 
hemolysis (Fig. 3 and Table VI). Sialic acid is common to HT, RT, HCG, and 
the surface of the red cells. It is postulated that immune hemolysis requires the 
enzymatic cleavage of a sialic acid-containing substrate from the cell surface. 
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When sialic acid-containing antigens are conjugated to the cell surface, such an 
enzymatic cleavage may be competitively inhibited and immune hemolysis by 
homologous antisera is suppressed. 
Hemolysis of Neuraminidase-Treated Red Cells by Guinea Pig Complement.-- 
If during immune hemolysis the enzymatic cleavage of a sialic acid-containing 
substrate from the cell surface precedes lysis, then the removal of sialic acid by 
neuraminidase should render the cell susceptible to lysis by complement in the 
absence of an immune reaction. In order to test this possibility, the hemolysis of 
neuraminidase-treated sheep red cells by C'a was compared with the hemolysis 
of the same cell preparation which had not been treated with neuraminidase. 
In these experiments both cell preparations were also exposed to heat-inacti- 
vated C'a and, as a further control,  to diluent (VBS) alone (Fig. 4). 852  INTERFERENCE WITH IMMUNE HEMOLYSIS 
Complement caused considerably more hemolysis of neuraminidase-treated 
cells than non-treated cells. The increased hemolysis appears to be dependent 
on complement activity, since inactivated C'a caused only trace amounts of 
hemolysis (Fig. 4). When the neuraminidase-treated cells were exposed to de- 
creasing amounts of C'~, decreasing degrees of hemolysis were observed (Fig. 5). 
The amount of lysis of neuraminidase-treated cells appears to be dependent 
upon the amount of sialic acid removed, since more hemolysis is observed when 
ceils are treated with 20 units of neuraminidase than with 10 units of neuramin- 
idase (Fig. 5). 
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It appears that when sialic acid is enzymatically removed from red cell sur- 
faces, complement will cause hemolysis in the absence of any known antigen- 
antibody reaction. 
Inhibition  of Hemolysis of Neuraminidase-Treated Cells by Sialic Acid--Con- 
taining Glycoproteins.--If sialic acid inhibits the hemolytic action of comple- 
ment, then a  siailc acid-containing protein conjugated to the surface of neu- 
raminidase-treated red cells should inhibit the lysis of these cells by comple- 
ment (Fig. 6). 
In  these  experiments,  sheep  red  cells  were  incubated  with  20  units  of 
neuraminldase and divided into two equal aliquots. One aliquot was sensitized 
with RT and the second aliquot served as control. Equal amounts of each of 
these red cell preparations were incubated with decreasing amounts of C'~ (Fig. 
6). The neuraminidase-treated cells to which RT was conjugated were lysed to 
a lesser degree than the cells treated with neuraminidase alone. ARQUILLA,  HA~LIN,  HAM.AS]HOE, AND  MILLER  853 
This observation further supports the postulate that during immune hemol- 
ysis sialic acid-containing substrate is enzymatically cleaved from the cell sur- 
face prior to lysis of the red cell. 
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DISCUSSION 
The agreement  between hemagglutination  and immune hemolysis titers of 
insulin antisera has also been observed with antisera directed toward other pro- 
tein antigens; e.g., egg albumin, bovine serum albumin, human 7-globulin,  and 
ferritin.  Occasional discrepancies between hemagglutination and immune hemol- 
ysis titers of individual guinea pig insulin antisera have been noted. This occurs 
early in immunization, and may possibly be related to the increased amounts of 
non-complement-fixing  71-antibodies  and  a  relatively small concentration  of 
complement-fixing  7rantibodies  described by Bloch,  Kourilsky, Ovary,  and 
Benacerraf (16). Such discrepancies,  however, are not as marked as the differ- 
ence between the hemolytic and hemagglutination  titers of the glycoprotein 
antisera studied in these experiments. Complement fixation was observed with 
the three sialic  acid-containing  glycoprotein immune systems which were in- 
vestigated. Therefore,  reduced immune  hemolysis cannot  be attributed  to a 
relative absence of complement-fixing  7rantibodies in the antisera. 
In our laboratory the immune hemolytic titers with human 7-globulin anti- 
gen are comparable to hemagglutination  titers. Human ~,-globulin contains at 
least one molecule of sialic acid per molecule  of 7-globulin (17). Both human 854  INTERFEP~NCE  WITtt  IMMUNE  H]~MOL~SIS 
transferrin and rabbit transferrin contain four molecules of sialic acid per mole- 
cule of transferrin. 
The inability of human "r-globulin to interfere with immune hemolysis may 
be due either to the relative paucity of sialic acid or to the position of the sialic 
acid in the molecule. 
Eylar estimated that the surface of a sheep (lamb) red cell contains 7.6 ×  10  e 
sialic acid molecules (10). Roberts and Haurowitz (18) estimated that the opti- 
mal sensitization of sheep red cells with antigen, using the BDB method, re- 
quires 5 X  10  5 molecules of antigen per cell. Transferrin contains four molecules 
of sialic acid. Consequently, a cell after optimal sensitization with transferrin, 
probably contains 2 X  10  e additional sialic acid molecules. This is in good agree- 
ment with the total number of sialic acid moieties on the surface of a sheep red 
cell (10). This circumstantial evidence might possibly indicate that most of the 
sialic acid moieties on the cell surface are implicated in the process of immune 
hemolysis. 
The hemolysis of de-sialicated red cells by guinea pig complement in the ab- 
sence of any known immune reaction raises the provocative possibility that red 
cells deficient in sialic acid may be lysed spontaneously by complement. All the 
C', used in these experiments had been adsorbed with relatively large quantities 
of sheep red cell stroma to remove materials present in complement which re- 
sult in the spontaneous hemolysis of sheep red cells (2). In addition, it was as- 
sumed that any naturally occurring antibody-like materials were removed by 
this adsorption procedure. The possibility does exist that after treatment with 
neuraminidase, sites are made available on the surface of red cells which may 
not have been exposed in the non-treated red cells. Such newly exposed sites 
could possibly react with guinea pig globulins in such a way as to activate the 
complement system and result in a form of immune hemolysis. It is important, 
therefore, that the hemolysis of neuraminidase-treated ceils with various com- 
plement reagents be investigated, in order to determine whether  de-sialicated 
cells are spontaneously lysed by certain components of the complement system. 
These experiments are currently being performed. 
The observations noted in  this investigation suggest that during immune 
hemolysis a  sialic acid-containing substrate  is  cleaved from the  cell surface 
prior to hemolysis of the red ceil. It is further suggested that the removal of 
sialic acid involves the antigen-antibody combination, in addition to one or 
more complement components. Hemolysis can be caused by complement in the 
absence of any known immune reaction when the erythrocytes are de-sialicated. 
The actual removal of sialic acid from the cell surface during the various stages 
of immune hemolysis has not been demonstrated. 
When sialic acid-containing protein was  conjugated to  the surface of de- 
sialicated red cells, lysis of these cells by complement was inhibited (Fig. 6). 
This is probably due to a competition between the sialic acid of the RT and the ARQUILLA, HAMLIN, HAMASHIGE, AND MILLER  855 
sialic acid on the surface of the red cells prior to the lyric phase of the hemolysis 
reaction. This substantiates the postulate that during lysis of the cell by com- 
plement, the sialic acid moiety is removed from the cell surface. It is not known 
at which phase  during immune hemolysis the  sialic acid moiety is cleaved. 
Methods are available which should permit such determination. 
S~AR¥ 
1.  The titer of an individual insulin antiserum measured by hemagglutination 
agrees favorably with the titer of the same antiserum as measured by immune 
hemolysis. 
2.  In contrast, a  marked decrease is noted in the immune hemolysis titers 
relative to hemagglutination titers of antisera prepared against three different 
sialic acid-containing proteins  (human chorionic gonadotropin, rabbit  trans- 
ferrin, and human transferrin). 
3.  The lower immune hemolytic titers of glycoprotein antisera are apparently 
not due to a lack of complement-fixing ~-antibodies. 
4.  The glycoprotein antigens in solution do not interfere with hemolysis in the 
insulin immune system. 
5.  By contrast, marked inhibition of insulin immune hemolysis occurs when 
cells are sensitized with both glycoprotein and insulin. 
6.  Cells treated with neuraminidase (to remove cell surface siaiic acid) lyse 
in the presence of C'~ alone. 
7.  If neuraminidase-treated cells  are  sensitized with  sialic acid-containing 
protein, the lysis of these cells by complement is inhibited. 
8.  It is,  therefore, postulated that during some initial phase of immune he- 
molysis, a sialic acid-containing substrate is cleaved from the cell surface, ren- 
dering the cell susceptible to lysis. If this removal is interfered with, i.e., by sen- 
sitization of the cell with competitive siaiic acid-containing antigen, then the 
lytic portion of immune hemolysis cannot proceed. 
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